Skip to main content

Immunosuppressive Agents and Intestinal Involvement

  • Chapter
  • First Online:
  • 448 Accesses

Abstract

Infections, including opportunistic infections, are frequently encountered in clinical practice for rheumatic diseases; such infections represent important complications that can affect the prognosis for survival. While steroids, immunosuppressive agents, and other drugs used to treat them increase the risk of infections, the increased incidences of opportunistic infections associated with the use of biologics have recently been posing a grave concern. In the gastrointestinal tract, cytomegalovirus and candida infections are common and can sometimes be fatal; therefore, it is important that the physician engaged in clinical practice for rheumatic diseases endeavor to detect and treat such infections as early as possible and consistently be aware of complications.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Falagas ME, et al. Infection-related morbidity and mortality in patients with connective tissue disease: a systematic review. Clin Rheumatol. 2007;26:663–70.

    Article  Google Scholar 

  2. Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol. 2003;15:528–34.

    Article  CAS  Google Scholar 

  3. Juarez M, et al. Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Rheum Dis Clin North Am. 2003;29:163–84.

    Article  Google Scholar 

  4. Doran MF, et al. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002;46:2287–93.

    Article  Google Scholar 

  5. Kodsi BE, Wickremesinghe C, Kozinn PJ, et al. Candida esophagitis: a prospective study of 27 cases. Gastroenterology. 1976;71:715–9.

    CAS  PubMed  Google Scholar 

  6. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med. 2001;345:1098–104.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyoko Katakura .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Katakura, K., Migita, K., Ohira, H. (2019). Immunosuppressive Agents and Intestinal Involvement. In: Ohira, H., Migita, K. (eds) Gastrointestinal and Hepatic Manifestations of Rheumatic Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-13-6524-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-6524-9_12

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-6523-2

  • Online ISBN: 978-981-13-6524-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics